PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

PTEN haploinsufficiency is common in hormone-sensitive prostate cancer, though the incidence of genomic deletion and its downstream effects have not been elucidated in clinical samples of hormone refractory prostate cancer (HRPC). Progression to androgen independence is pivotal in prostate cancer an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pathology 2009-08, Vol.218 (4), p.505-513
Hauptverfasser: Sircar, Kanishka, Yoshimoto, Maisa, Monzon, Federico A, Koumakpayi, Ismael H, Katz, Ruth L, Khanna, Abha, Alvarez, Karla, Chen, Guanyong, Darnel, Andrew D, Aprikian, Armen G, Saad, Fred, Bismar, Tarek A, Squire, Jeremy A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!